Literature DB >> 15056597

Stress and the genesis of diabetes mellitus in schizophrenia.

Timothy G Dinan1.   

Abstract

BACKGROUND: The incidence of diabetes mellitus is higher in patients with schizophrenia than in the general population. Antipsychotic drugs have been implicated in the development of diabetes, but as non-medicated patients with schizophrenia have high rates of diabetes it is likely that factors other than medication are involved. AIM: To examine the role of stress in the emergence of diabetes mellitus in patients with schizophrenia.
METHOD: Selective literature review.
RESULTS: A model is developed suggesting that patients with schizophrenia show over activation of both the hypothalamic-pituitary-adrenal and sympathoadrenal medullary axes, manifested by increased production of cortisol and adrenaline. Both of these hormones are known to be diabetogenic and are proposed as playing a part in the onset of diabetes mellitus in schizophrenia.
CONCLUSIONS: Stress has an important role in the onset of schizophrenia and may also play a part in relapse. Further research is needed to clarify the extent to which stress accounts for the genesis of diabetes in such patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056597     DOI: 10.1192/bjp.184.47.s72

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  11 in total

Review 1.  Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

Authors:  Leslie Citrome; Richard I G Holt; Daniel J Walker; Vicki Poole Hoffmann
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  The physiological effects of Shinrin-yoku (taking in the forest atmosphere or forest bathing): evidence from field experiments in 24 forests across Japan.

Authors:  Bum Jin Park; Yuko Tsunetsugu; Tamami Kasetani; Takahide Kagawa; Yoshifumi Miyazaki
Journal:  Environ Health Prev Med       Date:  2010-01       Impact factor: 3.674

3.  Acute psychosis and type 2 diabetes mellitus:should screening guidelines be revised?

Authors:  Leah K Bauer; Lawson R Wulsin; Gina Guadagno
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Choroid Plexus Enlargement and Allostatic Load in Schizophrenia.

Authors:  Yan-Fang Zhou; Jun-Chao Huang; Ping Zhang; Feng-Mei Fan; Song Chen; Hong-Zhen Fan; Yi-Min Cui; Xing-Guang Luo; Shu-Ping Tan; Zhi-Ren Wang; Wei Feng; Ying Yuan; Fu-De Yang; Anya Savransky; Meghann Ryan; Eric Goldwaser; Joshua Chiappelli; Laura M Rowland; Peter Kochunov; Yun-Long Tan; L Elliot Hong
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

5.  Ziprasidone decreases cortisol excretion in healthy subjects.

Authors:  Andreas Meier; Anna-Catharina Neumann; Wolfgang Jordan; Gerald Huether; Andrea Rodenbeck; Eckart Rüther; Stefan Cohrs
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

6.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

7.  Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients.

Authors:  N Hepgul; C M Pariante; S Dipasquale; M DiForti; H Taylor; T R Marques; C Morgan; P Dazzan; R M Murray; V Mondelli
Journal:  Psychol Med       Date:  2012-01-20       Impact factor: 7.723

8.  Homocysteine, cortisol, diabetes mellitus, and psychopathology.

Authors:  K Kontoangelos; C C Papageorgiou; A E Raptis; P Tsiotra; V Lambadiari; G N Papadimitriou; A D Rabavilas; G Dimitriadis; S A Raptis
Journal:  J Diabetes Res       Date:  2015-02-01       Impact factor: 4.011

9.  Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review.

Authors:  Rébecca Robillard; Naomi L Rogers; Bradley G Whitwell; Tim Lambert
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-04-30       Impact factor: 2.582

10.  Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.

Authors:  Giulio Scigliano; Gabriele Ronchetti
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.